
- Erscheinungsweise vierteljährlich
- ca. 70 Seiten
- ISSN 2751-3971
- eISSN 2751-398X
- Sprache: Englisch
EHPL – European Health & Pharmaceutical Law Review
EHPL 2/2025 Out Now
The second issue of the European Health & Pharmaceutical Law Review (EHPL) for 2025 is now available! This edition features a selection of thought-provoking articles and reports on critical developments in health and pharmaceutical law.
Articles:
Opportunities vs. Opportunism: Competition Law and New Regulatory Perspectives on Combination Therapies by Luca Arnaudo
Improving Access to Orphan Medicines: Towards a Pharmaceutical Duty of Care by André den Exter
This issue also includes the following reports:
A New Reimbursement Law in Poland Is Forthcoming – Will It Enhance Access to Medicines? Part II by Agnieszka Sztoldman and Piotr Płachecki
Environmental Risk Assessment of Pharmaceuticals Under Review: Legal Challenges and Opportunities of a Monograph System by Kim Teppe and Ulrich M. Gassner
Will Technology Disrupt Healthcare? Navigating the Regulatory Landscape by Tine Carmeliet and Eline D’Joos
Sie möchten einen Beitrag einreichen oder zur Weiterentwicklung der EHPL beitragen? Dann nutzen Sie unseren Call for Papers (englischsprachig). Weitere Details zur EHPL finden Sie auf der englischsprachigen Website.